Drugs in development: bisphosphonates and metalloproteinase inhibitors

被引：39

作者：

Catterall, JB ^{[1
]}

Cawston, TE ^{[1
]}

机构：

[1] Newcastle Univ, Sch Med, Dept Rheumatol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England

来源：

ARTHRITIS RESEARCH & THERAPY | 2003年 / 5卷 / 01期

关键词：

bone; cartilage; collagen; metalloproteinases; tissue inhibitor of metalloproteinase;

D O I：

10.1186/ar604

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The destruction of bone and cartilage is characteristic of the progression of musculoskeletal diseases. The present review discusses the developments made with two different classes of drugs, the bisphosphonates and matrix metalloproteinase inhibitors. Bisphosphonates have proven to be an effective and safe treatment for the prevention of bone loss, especially in osteoporotic disease, and may have a role in the treatment of arthritic diseases. The development of matrix metalloproteinase inhibitors and their role as potential therapies are also discussed, especially in the light of the disappointing human trials data so far published.

引用

页码：12 / 24

页数：13

共 140 条

[1] AMMANN P, 1993, J BONE MINER RES, V8, P1491
[2] TNF-α converting enzyme (TACE) is inhibited by TIMP-3
Amour, A
Slocombe, PM
Webster, A
Butler, M
Knight, CG
Smith, BJ
Stephens, PE
Shelley, C
Hutton, M
Knäuper, V
Docherty, AJP
Murphy, G
[J]. FEBS LETTERS, 1998, 435 (01) : 39 - 44
[3] [Anonymous], BISPHOSPHONATES BONE
[4] Clinical trials of a matrix metalloproteinase inhibitor in human periodontal disease
Ashley, RA
[J]. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 : 335 - 346
[5] Identification of adenine nucleotide-containing metabolites of bisphosphonate drugs using ion-pair liquid chromatography-electrospray mass spectrometry
Auriola, S
Frith, J
Rogers, MJ
Koivuniemi, A
Mönkkönen, J
[J]. JOURNAL OF CHROMATOGRAPHY B, 1997, 704 (1-2): : 187 - 195
[6] Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation
Balbín, M
Fueyo, A
Knäuper, V
López, JM
Alvarez, J
Sánchez, LM
Quesada, V
Bordallo, J
Murphy, G
López-Otín, C
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (13) : 10253 - 10262
[7] THE EFFECTS OF 2-YEAR TREATMENT WITH THE AMINOBISPHOSPHONATE ALENDRONATE ON BONE METABOLISM, BONE HISTOMORPHOMETRY, AND BONE STRENGTH IN OVARIECTOMIZED NONHUMAN-PRIMATES
BALENA, R
TOOLAN, BC
SHEA, M
MARKATOS, A
MYERS, ER
LEE, SC
OPAS, EE
SEEDOR, JG
KLEIN, H
FRANKENFIELD, D
QUARTUCCIO, H
FIORAVANTI, C
CLAIR, J
BROWN, E
HAYES, WC
RODAN, GA
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) : 2577 - 2586
[8] Barrera P, 2000, ARTHRITIS RHEUM-US, V43, P1951, DOI 10.1002/1529-0131(200009)43:9<1951::AID-ANR5>3.0.CO
[9] 2-K
[10] BARRETT AJ, 1998, HDB PROTEOLYTIC ENZY, pR25

← 1 2 3 4 5 6 7 8 9 10 →